John Sununu's Fiscal Policies Raise Questions on Debt Reduction Claims

Evaluating John Sununu's Stance on National Debt As he campaigns for the U.S. Senate in New Hampshire, Republican John Sununu emphasizes his commitment to reducing the national debt. However, a closer examination of his legislative history reveals a pattern of supporting policies that are believed to contribute to an increase in the national deficit. In a recent campaign ad, Sununu highlighted the necessity of addressing the national deficit, stating, “People definitely want to see us cut the deficit.” His focus is on implementing strategies that aim at economic growth, spending control, and annual deficit reduction. Notably, Sununu's support for the One Big Beautiful Bill Act (OBBB) raises questions about his commitment to debt reduction. He claimed the measure would help decrease the deficit and would have a limited impact on national debt, dismissing counterarguments as “liberal math.” However, a Congressional Budget Office report contradicted this assertion, indicating that the OBBB would actually add around $3.4 trillion to the deficit over a ten-year period. Additionally, the Bipartisan Policy Center projected a more profound impact, estimating an increase of over $4 trillion in the national debt due to this legislation, which includes interest expenses. Echoing a similar trend, Sununu championed the 2017 Tax Cuts and Jobs Act (TCJA), which he believed would enhance the competitiveness of U.S. businesses. A report from the Tax Policy Center suggests that TCJA would increase the deficit by approximately $1.5 trillion by 2034. Sununu's financial investments reflect a vested interest in industries that have directly benefited from these policies. The OBBB notably provided significant subsidies to fossil fuel producers, while the TCJA enabled increased exploration activities in the Arctic National Wildlife Refuge. His financial disclosures indicate holdings that include investments valued at up to $50,000 in ExxonMobil and up to $65,000 in Shell. Moreover, pharmaceutical companies also profited under these laws. The OBBB exempted certain drugs from Medicare price negotiations, leading to an additional payout of $5 billion to manufacturers as noted by the Congressional Budget Office. In a separate intervention, the TCJA reduced corporate taxes for pharmaceutical firms significantly, saving them about $6 billion. Sununu’s portfolio reportedly contains up to $425,000 in investments related to pharmaceutical stocks, including interests in major companies like Pfizer and Merck. Additionally, during his time in the U.S. House, he was supportive of previous tax cuts, such as the Economic Growth and Tax Relief Reconciliation Act and the Jobs and Growth Tax Relief Reconciliation Act, collectively known as the Bush tax cuts, which added an estimated $1.7 trillion to the deficit. With Sununu endorsed by Trump, he is gearing up to face Democratic Rep. Chris Pappas in the coming November elections.